These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32794429)

  • 1. Association of cigarette smoking and adverse events in left ventricular assist device patients.
    Youmans QR; Zhou A; Harap R; Eskender MH; Anderson AS; Ezema AU; Ghafourian K; Ohiomoba R; Pham DT; Rich JD; Vorovich EE; Wilcox JE; Yancy CW; Okwuosa IS
    Int J Artif Organs; 2021 Mar; 44(3):181-187. PubMed ID: 32794429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tobacco smoking on outcomes after left ventricular assist device implantation.
    Combs P; Imamura T; Siddiqi U; Spiller RE; Williamson R; Mirzai S; Symalla T; LaBuhn C; Jeevanandam V
    Artif Organs; 2020 Jul; 44(7):693-699. PubMed ID: 32017136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 6. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device.
    Cho SM; Moazami N; Katz S; Bhimraj A; Shrestha NK; Frontera JA
    Neurocrit Care; 2019 Aug; 31(1):72-80. PubMed ID: 30644037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and the Risk of Stroke in Patients with a Left Ventricular Assist device.
    Sherazi S; Goldenberg I; McNitt S; Kutyifa V; Gosev I; Wood K; Chen L; Polonsky B; Vidula H; Alexis JD
    ASAIO J; 2021 Nov; 67(11):1217-1221. PubMed ID: 34049312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump.
    Kormos RL; McCall M; Althouse A; Lagazzi L; Schaub R; Kormos MA; Zaldonis JA; Sciortino C; Lockard K; Kuntz N; Dunn E; Teuteberg JJ
    Circulation; 2017 Oct; 136(18):1714-1725. PubMed ID: 28674109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
    Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
    Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange.
    Urban M; Um J; Moulton M; Stoller D; Zolty R; Lowes B; Macdonald C; McCain N; Siddique A
    Int J Artif Organs; 2020 Feb; 43(2):109-118. PubMed ID: 31530254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapy.
    Thohan V; Shi Y; Rappelt M; Yousefzai R; Sulemanjee NZ; Hastings TE; Cheema OM; Downey F; Crouch JD
    J Card Surg; 2019 Jun; 34(6):453-462. PubMed ID: 31058372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
    Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
    J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.